Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Accelerating Medicines Partnership Program - Bespoke Gene Therapy Consortium (AMP BGTC) Annual Meeting

The Accelerating Medicines Partnership Program - Bespoke Gene Therapy Consortium (BGTC), managed by the Foundation for the National Institutes of Health (FNIH), is a public-private partnership consisting of multiple NIH ICs, the FDA, and numerous bio/pharma companies and patient advocacy organizations. The goal of the BGTC is to accelerate the development of gene therapies to treat genetic diseases of no commercial interest by developing: (1) a mechanistic understanding of AAV biology and factors that influence AAV gene expression and vector production; and (2) a gene therapy playbook, which will be a public resource that leverages best-practices templates, master regulatory files, and aligned manufacturing and testing processes. This playbook approach will be stress-tested through multiple clinical trial test cases, providing insights which will streamline the regulatory process for future gene therapy development for genetic diseases of no commercial interest. This workshop at ASGCT will serve as BGTC's first annual meeting, during which we will update on our progress so far, including AAV biology, the clinical program, and playbook development, engage the community on next steps, and provide member and patient perspectives on overcoming the challenges faced in the gene therapy field.

Session Details

Playbook User Engagement

Amritha Jaishankar, PhD. IQVIA, MA

Playbook User Engagement

Carmen Sivakumaren. IQVIA, NC

Playbook User Engagement

Jenny Fam. IQVIA, NC

Co-Chair

Michael Lehmicke, MS. Alliance for Regenerative Medicine, DC

Panelist

Sadik Kassim, PhD. Danaher Genomic Medicines, Boston, MA

Panelist

Debra Miller. CureDuchenne, CA

Panelist

Peter Marks. Food & Drug Administration, Silver Spring, MD

Panelist

PJ Brooks, PhD. Division of Rare Diseases Research Innovation, NCA, MD

Co-Chair

Courtney Silverthorn, PhD. Foundation for the National Institutes of Health (FNIH), North Bethesda, ...

BGTC Program Overview

Courtney Silverthorn. Foundation for the National Institutes of Health (FNIH), North Bethesda, MD

Overview of AAV Biology Awards

Junghae Suh, PhD. Biogen, TX

Overview of the BGTC Clinical Program

Edward Neilan, MD, PhD. National Organization for Rare Disorders (NORD), Quincy, MA

California Institute for Regenerative Medicine (CIRM)

Shyam Patel, PhD. CIRM, CA

California Institute for Regenerative Medicine (CIRM)

Abla Creasey, PhD. California Institute for Regenerative Medicine, South San Francisco, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.